Expression Analysis (EA), a leading provider of genomic services for clinical trials and research, announced today it has received CLIA (Clinical Laboratory Improvement Act) certification. This milestone comes as the company enters its tenth year of providing genomic expertise; something the company refers to as "Genomic Know-How™".
"We are excited about the addition of clinical laboratory testing to our service offerings and this certification further validates EA's operational and organizational excellence," said Steve McPhail, President and CEO of EA. "For ten years EA has delivered exceptional services and our clients have come to expect the highest quality work with the ability to overcome challenging scientific hurdles. With this certification, our clients can be confident of our continued commitment to their success."